Literature DB >> 2590718

Cell-mediated immune responses to sperm antigens: effects on mouse sperm and embryos.

R K Naz1, K Mehta.   

Abstract

Sperm antigens were assessed for their ability to induce cell-mediated immune (CMI) responses. Purified fertilization antigen (FA-1), protamine, and the lithium diiodosalicylate (LIS)-solubilized sperm preparation activated presensitized lymphocytes to secrete soluble mediators that activated macrophages and significantly inhibited sperm motility and embryonic development. The FA-1, however, was the most potent antigen in inducing proliferative response as well as the release of soluble mediators. LIS-sperm preparation, which contained numerous antigens, showed the least activity. The unsensitized control spleen cells did not secrete any factor(s) when activated with the antigen. In conclusion, these results indicate that sperm antigens can specifically induce (CMI) factors that have detrimental effects on sperm motility and preimplantation embryos. These findings may have potential clinical implications for humans, especially in immunologic and unexplained infertility, recurrent abortions, and development of antisperm contraceptive vaccines.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2590718     DOI: 10.1095/biolreprod41.3.533

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  3 in total

1.  Fertilization antigen-1: cDNA cloning, testis-specific expression, and immunocontraceptive effects.

Authors:  X Zhu; R K Naz
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

Review 2.  Vaccine for human contraception targeting sperm Izumo protein and YLP12 dodecamer peptide.

Authors:  Rajesh K Naz
Journal:  Protein Sci       Date:  2014-04-22       Impact factor: 6.725

3.  Sperm cells induce distinct cytokine response in peripheral mononuclear cells from infertile women with serum anti-sperm antibodies.

Authors:  Miloslav Kverka; Zdenka Ulcova-Gallova; Jirina Bartova; Jan Cibulka; Katarina Bibkova; Zdenka Micanova; Helena Tlaskalova-Hogenova
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.